The objective of this study was to assess the clinical efficacy and safety of meloxicam suspension 0.25 mg/kg/day once a day, versus diclofenac suspension 1 mg/kg/day twice a day or nimesulide suspension 4 mg/kg/day twice a day, after five days of treatment in patients with a diagnosis of acute, non-bacterial pharyngitis, pharyngotonsillitis or laryngitis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
128
Change in spontaneous pharyngeal pain
Time frame: baseline, 5 days
Change in pharyngeal pain on deglutition (dysphagia)
Time frame: baseline, 5 days
Change in pharyngeal hyperemia
Time frame: baseline, 5 days
Change in systemic manifestations (fever, adenomegaly and general malaise)
Time frame: baseline, 5 days
Incidence of adverse events
Time frame: baseline, 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.